how to wean from semaglutide Stop Safely: Weaning Guide How Long Does Semaglutide Take

Dual-agonist robi to samo na osi GLP-1, plus dokada agonizm receptora GIP: dodatkowy insulinotropizm i modulacj metabolizmu lipidw w tkance tuszczowej

Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect

Mechanism of Action: GLP-1 is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that belongs to a class of drugs called incretin mimetics

For the time being, though, the market is still dominated by two names: Eli Lilly and Co